Ponentes y moderadores
Michael Trauner, MD, received his medical education at the Karl-Franzens-University in Graz, Austria, where he also completed his clinical training in internal medicine and gastroenterology / hepatology. From 1994 to 1997 he was postdoctoral research fellow at Yale University’s Department of Internal Medicine and Liver Center in New Haven, USA. After returning to Graz, he established an internationally recognized research group in cholestatic and steatotic liver diseases, and founded the Liver Center, serving as professor of experimental and clinical hepatology from 2005-2010. Since 2010 he has been professor and chair gastroenterology and hepatology at the Medical University of Vienna. Dr. Trauner’s main research interests are the molecular mechanisms of bile acid transport and signaling in cholestatic and steatotic liver disease, the mechanisms of cell injury and fibrosis in these disorders, and the development of novel pharmacologic treatments for cholestatic and metabolic liver diseases. He has published more than 800 peer-reviewed scientific papers listed in Pubmed (highly cited researcher 2023 & 2024 / ISI Clarivate), 50 book chapters and has edited 3 books, he also holds 2 patents on the treatment of cholestatic and metabolic liver diseases.
Dr. Trauner is past president of the Austrian Society of Gastroenterology and Hepatology, member of the Austrian Academy of Sciences and the German National Academy of Sciences Leopoldina, as well as member of several national and international professional and scientific societies. He has served on several editorial boards and scientific committees, such as the European Association for the Study of the Liver (EASL) Governing Board and the United European Gastroenterology Council. He has also served as associate editor of Journal of Hepatology (2000 – 2009, and since 2020-ongoing) and Hepatology (2009-2021).